A validated HPLC assay to monitor riluzole plasma or serum concentrations in patients with amyotrophic lateral sclerosis

Biomedical Chromatography : BMC
H J M Van KanH-J Guchelaar

Abstract

A specific, accurate and precise high-performance liquid chromatographic assay was developed for the determination of riluzole, a drug used to treat patients with amyotrophic lateral sclerosis. Samples were treated by extraction with dichloromethane followed by reversed-phase chromatography with ultraviolet detection at 260 nm. Preset validation criteria were met from 20 to 2000 ng/mL with a linear response curve. Extraction recovery of riluzole was 65-76%. The accuracy of the method was 102-103%. Intra- and inter-day coefficients of variation were in the ranges 2.8-4.9% and 1.8-9.7%. A detection limit of 5 ng/mL was found. Determination of concentrations in serum and plasma resulted in similar results below 500 ng/mL. At higher values a matrix effect cannot be excluded. This presented method can be used to monitor plasma or serum levels in ALS patients treated with riluzole.

References

Mar 3, 1994·The New England Journal of Medicine·G BensimonV Meininger
Dec 9, 1997·Clinical Pharmacology and Therapeutics·R BrunoG R Rhodes
Apr 29, 1998·Journal of Clinical Pharmacology·A Le LibouxG Montay

❮ Previous
Next ❯

Citations

Aug 5, 2010·Analytical and Bioanalytical Chemistry·Babu Rao ChanduMukkanti Khagga
Oct 2, 2013·Indian Journal of Pharmaceutical Sciences·T NeehaB N Nalluri
Jun 8, 2013·Journal of Chromatographic Science·Ola A SalehAmr M Badawey
Sep 19, 2012·Journal of Neurosurgery. Spine·Diana S L ChowRobert G Grossman
Jun 18, 2017·Biomedical Chromatography : BMC·Suzanne L ParkerSteven C Wallis
Mar 9, 2005·British Journal of Clinical Pharmacology·H J M van KanH J Guchelaar
Sep 28, 2007·Clinical Pharmacology and Therapeutics·G J GroeneveldL H van den Berg

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Adriana MalteseClaudio Bucolo
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Milena ColovicSilvio Caccia
© 2021 Meta ULC. All rights reserved